Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Search Results
Cisplatin Injection
Status: Currently in Shortage
»Date first posted:
02/10/2023
»Therapeutic Categories: Oncology; Pediatric
Accord Healthcare Inc. (Revised 05/12/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1 mg/mL, 50 mL, multi-dose vial (NDC 16729-288-11) | Limited Availability | Marketed by Accord Healthcare. Current inventory is being allocated, further availability pending return to manufacturing | Other |
| 1 mg/mL, 100 mL, multi-dose vial (NDC 16729-288-38) | Limited Availability | Marketed by Accord Healthcare. Current inventory is being allocated, further availability pending return to manufacturing | Other |
| 1 mg/mL, 50 mL, multi-dose vial (NDC 68001-283-27) | Limited Availability | Marketed by BluePoint Laboratories. Current inventory is being allocated, further availability pending return to manufacturing | Other |
| 1 mg/mL, 100 mL, multi-dose vial (NDC 68001-283-32) | Limited Availability | Marketed by BluePoint Laboratories. Current inventory is being allocated, further availability pending return to manufacturing | Other |
Fresenius Kabi USA, LLC (Revised 05/31/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1 mg/mL, 50 mL, multi-dose vial (NDC 63323-103-51) | Backordered. Next release June 2023. | Check wholesaler inventory | Demand increase for the drug |
| 1 mg/mL, 100 mL, multi-dose vial (NDC 63323-103-65) | Backordered. Next release June 2023. | Demand increase for the drug | |
| 1 mg/mL, 200 mL, multi-dose vial (NDC 63323-103-64) | Backordered. Next release June 2023. | Check wholesaler inventory | Demand increase for the drug |
Hikma Pharmaceuticals (Revised 05/16/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1 mg/mL, 50 mL, multi-dose vial (NDC 0143-9504-01) | This presentation is temporarily on backorder. | Additional lots will be available in the May - June 2023 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| 1 mg/mL, 100 mL, multi-dose vial (NDC 0143-9505-01) | This presentation is temporarily on backorder. | Additional lots will be available in the May - June 2023 timeframe. Product will be made available as it is released. | Demand increase for the drug |
HQ Specialty Pharma (Revised 04/28/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1 mg/mL, 200 mL, multi-dose vial (NDC 44567-511-01) | No stock – Next available end May 2023 | Marketed by WG Critical Care | Demand increase for the drug |
| 50 mg, vial (NDC 44567-530-01) | Allocation | Marketed by WG Critical Care | Demand increase for the drug |
Teva Pharmaceuticals (Reverified 05/23/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1 mg/mL, 50 mL, multi-dose vial (NDC 0703-5747-11) | Limited supply; Recovery expected Q4 2023 | Demand increase for the drug | |
| 1 mg/mL, 100 mL, multi-dose vial (NDC 0703-5748-11) | Available; Recovery expected Q3 2023 | Demand increase for the drug |